The effect of combination of Descurainia Sophia and Deracocephalum syrup on patients with irritable bowel syndrome with constipation

The effect of combination of Descurainia Sophia and Deracocephalum syrup on clinical symptoms and quality of life in patients with irritable bowel syndrome with predominant constipation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220104053626N5

Enrollment

Registered

2023-01-24

Start date

2023-02-20

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irritable bowel syndrome. Irritable bowel syndrome without diarrhea

Interventions

Intervention 1: Intervention group: Patients in the intervention group will take 10cc of Descurainia sophia and Dracocephalum syrup(manufactured by Tabriz Traditional Medicine Center) daily for one m

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: having IBS according to ROME IV criteria age above 18 having normal colonoscopy within 5 years willing to participate

Exclusion criteria

Exclusion criteria: pregnancy and lactation any history of drug reaction celiac disease recent use of probiotics,laxatives,antibiotics and anti inflammatory drugs such as NSAID and corticosteroides. history of inflammatory bowel disease( ulcerative colitis and crohn disease) any pathologic findings in colonoscopy

Design outcomes

Primary

Measure	Time frame
Patients quality of life. Timepoint: Before and after the intervention. Method of measurement: The quality of life questionnaire for patients with irritable bowel syndrome.;Stool stiffness. Timepoint: before and after intervention. Method of measurement: Patient Assessment of Constipation–Symptom(PAC-SYM) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasood faghih Dinevari

Tabriz University of Medical Sciences

dinvarim@tbzmed.ac.ir+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026